Skip to main content
. 2016 Jun 16;60(2):2629. doi: 10.4081/ejh.2016.2629

Table 2.

Clinicopathological characteristics and DKK3 expression in patients with oral submucous fibrosis.

No. of patients DKK3 expression χ2 P value
+(%) -(%)
Sex 0.000 1.000
   Male 26 13(50) 13(50)
   Female 4 1(25) 3(75)
Age (years) 2.143 0.143
   <31 14 5 (35.7) 9 (64.3)
   >31 16 10 (62.5) 6 (37.5)
Grade 4.563 0.130
   Early 5 4(80) 1(20)
   Moderate 16 9 (56.3) 7 (43.7)
   Advanced 9 2 (22.2) 7 (77.8)
Dysplasia status 19.286 0.0001*
   Dysplasia 16 2 (12.5) 14 (87.5)
   No dysplasia 14 13 (92.9) 1 (7.1)
Habit 0.556 0.456
   Betel nut 18 10 (55.6) 8 (44.4)
   Betel nut and smoking 12 5 (41.7) 7 (58.3)
Duration 0.133 0.715
   <8 years 15 8 (53.3) 7 (46.7)
   >8 years 15 7 (46.7) 8 (53.3)
Mouth opening 0.635 0.426
   <28 9 3 (33.3) 6 (77.7)
   >28 21 12 (57.1) 9 (42.9)
Stage/atrophy° 0.362 0.547
   Early stage/atrophic 2 2 0
   Moderate stage/atrophic 7 4 3
   Sever stage/atrophic 9 2 7

*Statistically significant at P<0.05;

°relation between epithelial atrophy and DKK3 expression according to Pindborg’s criteria.